IBM (NYSE: IBM) announced it is contributing a massive database of chemical data extracted from millions of patents and scientific literature to the National Institutes of Health. This contribution will allow researchers to more easily visualize important relationships among chemical compounds to aid in drug discovery and support advanced cancer research.

Consumers hold churches and pharmaceutical companies to different moral standards than other organizations, according to a new study in the Journal of Consumer Research.

Scientists have discovered a new way to target cancer through manipulating a master switch responsible for cancer cell growth. The findings, published in the journal Cancer Cell, reveal how cancer cells grow faster by producing their own blood vessels.

The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.

Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combatted in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing the replication of adenoviruses.

Springer Healthcare, part of Springer Science+Business Media, has signed an extensive three-year reprints and sales agreement effective 1 January 2012 with the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer.

Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term. The latest report by the World Health Organization (WHO), UNICEF and UNAIDS Report on the Global HIV/AIDS Response indicates that increased access to HIV services resulted in a 15% reduction of new infections over the past decade and a 22% decline in AIDS-related deaths in the last five years.